• Vaxil Locations
  • Contact Us
  • Subscribe
Vaxil Bio
  • About Vaxil
  • TEAM
  • INTELLECTUAL PROPERTY
  • News and Updates
  • In the Media

Author Archives: David Goren

13 Feb
Annnouncements

VAXIL ANNOUNCES THE IDENTIFICATION OF A POTENTIAL CORONA VIRUS VACCINE AND PROVIDES AN UPDATE IN THE PREVIOUSLY ANNOUNCED DEBT FINANCING

… Read the rest
Posted on February 13, 2020April 30, 2020 by David Goren
04 Nov
Annnouncements

VAXIL’S ANNUAL AND SPECIAL GENERAL MEETING

… Read the rest
Posted on November 4, 2019April 30, 2020 by David Goren
30 Oct
Annnouncements

VAXIL ANNOUNCES PRIVATE PLACEMENT EXTENSION

… Read the rest
Posted on October 30, 2019April 30, 2020 by David Goren
10 Sep
Annnouncements

Vaxil Announces Public Placement

… Read the rest
Posted on September 10, 2019April 30, 2020 by David Goren
30 Aug
Annnouncements

VAXIL APPOINTS NEW CHAIRMAN

… Read the rest
Posted on August 30, 2019April 30, 2020 by David Goren
Older posts

Vaxil Canada
First Canadian Place, 34th Floor, 100 King Street W., Toronto, Ontario. M2N 6N4 Canada

Vaxil Israel
3 Pinhas Sapir Street, 3rd Floor, Weizmann Science Park, 74140, Rehovot, Israel

Corporate

  • Home
  • About Vaxil
  • Vaxil Locations
  • Contact Us
  • Board & Executives
  • News and Updates

INVESTORS

  • Investor Presentations
  • Public Filings
  • News and Updates
  • In the Media
  • Video
  • Scientific Publications
Copyright 2023 © VAXIL BIO THERAPEUTICS | Vaxil Bio therapeutics is an Israeli biotech focused on cancer immunotherapy, based in the Weizmann Science Park in Rehovot, Israel. Vaxil is listed on the TSX-Venture as VXL
  • About Vaxil
  • TEAM
  • INTELLECTUAL PROPERTY
  • News and Updates
  • In the Media
  • Vaxil Locations
  • Contact Us
  • Subscribe